AG真人官方

Flagstar Financial, Inc. ("Company") has signed an Agreement and Plan of Merger with its wholly-owned subsidiary Flagstar Bank, N.A. ("Bank"). The parent will merge into the Bank, leaving the Bank as the surviving, publicly-traded entity.

• At closing, all outstanding common and Series A preferred shares will be cancelled and exchanged 1-for-1 for equivalent Bank shares; Series B and Series D preferred convert into substantially identical non-voting equity where required by law.
• Existing warrants will automatically become warrants on Bank common stock.
• The Bank will assume all assets, liabilities, debt obligations and incentive plans, and will keep the same board, executive team and NYSE ticker 鈥�FLG鈥�.
• The merger is intended to be a tax-free reorganisation under IRC 搂368(a); shareholders should not realise gain or loss.
• Boards of both entities have approved the deal; completion requires customary regulatory and special-meeting shareholder approvals.
• Post-merger, the Bank will report to the OCC rather than the SEC and will continue operating under the Flagstar brand nationwide.

No timetable, cost synergies or other financial terms were disclosed.

On 7/22/25 Unity Biotechnology (UBX) entered into a Purchase Agreement with President/Secretary and sole director Craig R. Jalbert to sell a single Series A Preferred Share for $1. The share carries 600,000,000 votes but may be used only on the forthcoming Dissolution Proposal and must mirror the proportion of votes actually cast by common shareholders. It is non-convertible, pays a $0.01 priority dividend and automatically transfers back to the company after the stockholder meeting.

The step is designed to neutralise abstentions and broker non-votes, effectively lowering the practical approval hurdle for the board-approved dissolution plan announced 6/27/25. UBX鈥檚 common stock was suspended from Nasdaq on 7/9/25 and now trades on OTC Pink (UNBX); a Form 25 will be filed to delist. The issuance was made under the 搂4(a)(2) private-placement exemption. This 8-K/A otherwise only adds the former address to the cover page.

On 07/21/2025, VeriSign Inc. (VRSN) director Debra McCann disclosed the receipt of 879 restricted stock units (RSUs), according to a Form 4 filed on 07/23/2025. Each RSU represents one share of common stock and vested 100% on the grant date, subject to tax withholding.

After the grant, McCann directly owns 1,880 VeriSign shares. No cash was paid (reported price $0) and no derivative securities were involved. The transaction is routine board compensation and represents an immaterial fraction of VeriSign鈥檚 outstanding shares, therefore unlikely to move the stock or alter the company鈥檚 capital structure.

VeriSign (VRSN) Form 4: Director Courtney D. Armstrong reported the award of 879 restricted stock units (RSUs) on 07/21/2025. Each RSU converts into one share and vested 100% on the grant date; therefore the transaction code is "A" (acquisition) at a grant price of $0. After settlement, Armstrong, through The Armstrong Family Trust, now beneficially owns 6,047.775 VeriSign common shares. No derivative securities were involved and there was no open-market purchase or sale. The filing represents routine equity compensation for a board member and increases Armstrong鈥檚 stake by an immaterial amount relative to VeriSign鈥檚 total shares outstanding.

Director Timothy Tomlinson filed a Form 4 disclosing receipt of 984 restricted stock units (RSUs) in VeriSign (VRSN) on 07/21/2025. Each RSU equals one common share and vested immediately on the grant date; no cash was paid ($0 acquisition price). After the award, the Tomlinson Family Trust holds 15,984 VeriSign shares indirectly. No sales, options, or other derivative transactions were reported. The grant represents routine director compensation and adds an immaterial number of shares to the company鈥檚 float, with no effect on earnings, guidance, or capital structure.

VeriSign Inc. (VRSN) 鈥� Form 4 insider filing, 23 Jul 2025

Director Jamie S. Gorelick disclosed receipt of 879 restricted stock units (RSUs) on 21 Jul 2025. Each RSU converts into one share of VeriSign common stock and vested 100 % on the grant date, subject to tax withholding. Following the award, Gorelick鈥檚 indirect holdings鈥攈eld via the Jamie S. Gorelick Revocable Trust鈥攖otal 22,254 common shares. No derivative securities were reported, and no shares were sold.

The transaction represents a modest incremental ownership change and is routine compensation for board service. It does not signal a material shift in ownership, capital structure, or near-term corporate outlook.

Alset Inc. (AEI) 8-K: On 23 Jul 2025 the company closed its purchase of New Energy Asia Pacific Inc. (NEAPI) from Chairman/CEO Chan Heng Fai for an $83 m, 1% promissory note convertible at $3.00 per share. Immediately after closing, Chan converted the entire note into 27.67 m restricted AEI shares, retiring the debt.

NEAPI owns 41.5 % of Hong-Kong based New Energy Asia Pacific Co., a distributor of all-electric specialty vehicles, charging stations and batteries. Management calls the deal a strategic push into sustainable transport, citing signed MOUs and 鈥渟trong interest鈥� from Asian municipal customers that could drive near-term revenue growth.

The all-stock consideration increases AEI鈥檚 outstanding share count and further concentrates insider ownership. Because the seller is AEI鈥檚 largest shareholder, the transaction is a related-party deal; the share issuance relied on the Section 4(a)(2) private-placement exemption.

Form 4 discloses that director Yehuda Ari Buchalter received 879 restricted stock units (RSUs) of VeriSign Inc. (VRSN) on 21 Jul 2025. Each RSU converts to one common share and vested immediately on the grant date; no cash consideration was paid.

• Post-transaction, Buchalter鈥檚 direct ownership rose to 4,614 shares, implying a 23% increase from the prior holding of roughly 3,735 shares.
• The award size represents an immaterial <0.001% of VeriSign鈥檚 ~110 M share count, creating negligible dilution.
• The filing is routine board compensation with no accompanying sales, signaling continued equity alignment but offering limited insight into operating performance or outlook.